ROSEMARIE SCHMANDT to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications ROSEMARIE SCHMANDT has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.031
-
Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models. Cancer Biol Ther. 2010 Feb; 9(3):176-82.
Score: 0.019
-
A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed m?llerian tumors with evaluation of potential molecular targets. Gynecol Oncol. 2003 Sep; 90(3):529-36.
Score: 0.012